Showing results (1-10 of 67) with videos related to
Sort By:
Pageof 7
Cancer Drug Resistance (Alhambra, Calif.)|July 26, 2021
Proteasomal adaptations to FDA-approved proteasome inhibitors: a potential mechanism for drug resistance?Kyung Bo KimCurrent Topics in Medicinal Chemistry|August 10, 2011
The immunoproteasome: an emerging therapeutic targetWooin Lee, Kyung Bo KimNatural Product Reports|April 12, 2013
From epoxomicin to carfilzomib: chemistry, biology, and medical outcomesKyung Bo Kim, Craig M CrewsCell Biochemistry and Biophysics|May 24, 2013
Activity-based imaging probes of the proteasomeKimberly Cornish Carmony, Kyung Bo KimMethods in Molecular Biology (Clifton, N.J.)|February 22, 2012
PROTAC-induced proteolytic targetingKimberly Cornish Carmony, Kyung-Bo KimCurrent Cancer Drug Targets|July 26, 2014
The immunoproteasome as a therapeutic target for hematological malignanciesZachary Miller, Wooin Lee, Kyung Bo KimChembiochem : a European Journal of Chemical Biology|September 9, 2016
High-Resolution Snapshots of Proteasome Inhibitors in Action Revise Inhibition Paradigms and Inspire Next-Generation Inhibitor DesignKimberly Carmony, Wooin Lee, Kyung Bo KimCurrent Protocols in Chemical Biology|July 10, 2013
Targeted Degradation of Proteins by PROTACsEun Ryoung Jang, Wooin Lee, Kyung Bo KimMolecular Biosystems|March 21, 2008
Proteasome modulators: essential chemical genetic tools for understanding human diseasesMarie Wehenkel, Jin Tae Hong, Kyung Bo KimMethods in Enzymology|December 13, 2005
Development and characterization of proteasome inhibitorsKyung Bo Kim, Fabiana N Fonseca, Craig M CrewsPageof 7